Yao, L., Wang, H., Liu, Y., Feng, M., Li, Y., Su, Z., . . . Zhou, Y. Combined anti-PD-L1 and anti-VEGFR2 therapy promotes the antitumor immune response in GBM by reprogramming tumor microenvironment. Nature Publishing Group.
Chicago Style (17th ed.) CitationYao, Lin, et al. Combined Anti-PD-L1 and Anti-VEGFR2 Therapy Promotes the Antitumor Immune Response in GBM by Reprogramming Tumor Microenvironment. Nature Publishing Group.
MLA (9th ed.) CitationYao, Lin, et al. Combined Anti-PD-L1 and Anti-VEGFR2 Therapy Promotes the Antitumor Immune Response in GBM by Reprogramming Tumor Microenvironment. Nature Publishing Group.
Warning: These citations may not always be 100% accurate.